Statistics about Health, Pharma & Medtech in United States
Statistics
- Bio-Techne Corp gross profit 2020-2024
- Third Harmonic Bio net cash 2021-2023
- Burzynski Research Institute total assets 2019-2023
- Moderna total assets 2019-2023
- Bridgebio Pharma net cash 2019-2023
- Curis net cash 2019-2023
- Cardiff Oncology liabilities 2019-2023
- Cardiff Oncology operating profit 2019-2023
- Cardiff Oncology revenue 2019-2023
- Curis operating profit 2019-2023
- Curis liabilities 2019-2023
- Cardiff Oncology total equity 2019-2023
- Curis revenue 2019-2023
- Neurocrine Biosciences net income 2016-2018
- Musclepharm revenue 2017-2021
- Neogen net income 2019-2023
- Curis total assets 2019-2023
- Alzamend Neuro total equity 2019-2023
- Curis total equity 2019-2023
- Natural Alternatives revenue 2020-2024
- Molecular Templates, Inc. revenue 2011-2019
- Cardiff Oncology total assets 2019-2023
- Cardiff Oncology net cash 2019-2023
- Tenaya Therapeutics liabilities 2020-2023
- Cti Biopharma Corp liabilities 2018-2022
- Alzamend Neuro liabilities 2020-2023
- Alzamend Neuro total assets 2019-2023
- Monopar Therapeutics total equity 2019-2023
- Cti Biopharma Corp net income 2018-2022
- Cti Biopharma Corp revenue 2018-2022
- Cti Biopharma Corp total equity 2017-2021
- Moderna total equity 2019-2023
- Natures Sunshine Products Inc net income 2019-2023
- Morphic Holding total equity 2019-2023
- Cti Biopharma Corp total assets 2018-2022
- Cti Biopharma Corp net cash 2018-2022
- Alzamend Neuro net cash 2019-2023
- Cti Biopharma Corp operating profit 2018-2022
- Navidea Biopharmaceuticals, Inc. net income 2018-2022
- Molecular Templates, Inc. net income 2022-2023
- Bridgebio Pharma operating profit 2019-2023
- Monopar Therapeutics liabilities 2019-2023
- Marker Therapeutics total assets 2019-2023
- Metacrine net cash 2019-2021
- Metacrine operating profit 2019-2021
- Tango Therapeutics, Inc. net cash 2020-2023
- Myriad Genetics operating profit 2019-2023
- Matinas Biopharma Holdings liabilities 2019-2023
- Coherus Biosciences net income 2019-2023
- Myriad Genetics liabilities 2019-2023
- Matinas Biopharma Holdings net cash 2019-2023
- Myriad Genetics revenue 2019-2023
- Myriad Genetics net cash 2019-2023
- Metacrine total assets 2019-2021
- Beam Therapeutics total assets 2019-2023
- Beam Therapeutics revenue 2019-2023
- Matinas Biopharma Holdings total assets 2019-2023
- Metacrine total equity 2018-2021
- Beam Therapeutics total equity 2019-2023
- Matinas Biopharma Holdings operating profit 2019-2023
- Coherus Biosciences operating profit 2019-2023
- Matinas Biopharma Holdings total equity 2019-2023
- Tonix Pharmaceuticals Holding net cash 2019-2023
- Miromatrix Medical Inc. total equity 2019-2022
- Mirum Pharmaceuticals total equity 2019-2023
- Mersana Therapeutics total assets 2019-2023
- Mirati Therapeutics total assets 2018-2022
- Tenaya Therapeutics net cash 2020-2023
- Marpai total equity 2019-2023
- Merck & Co total equity 2019-2023
- Matinas Biopharma Holdings revenue 2019-2023
- Marker Therapeutics total equity 2019-2023
- Mersana Therapeutics total equity 2019-2023
- Mirati Therapeutics total equity 2018-2022
- Metacrine net income 2019-2021
- Matinas Biopharma Holdings net income 2019-2021
- Myriad Genetics net income 2018-2022
- Coherus Biosciences revenue 2019-2023
- Myriad Genetics total assets 2019-2023
- Beam Therapeutics net cash 2019-2023
- Moderna operating profit 2019-2023
- Ngm Biopharmaceuticals Inc liabilities 2019-2023
- Monopar Therapeutics net income 2021-2022
- Morphic Holding net income 2019-2023
- Moderna revenue 2019-2023
- Morphic Holding revenue 2019-2023
- Monopar Therapeutics operating profit 2019-2023
- Trex Wind-Down, Inc. net cash 2018-2022
- Caribou Biosciences liabilities 2020-2023
- Monte Rosa Therapeutics liabilities 2020-2023
- Caribou Biosciences total assets 2020-2023
- Caribou Biosciences net cash 2019-2023
- Caribou Biosciences net income 2019-2023
- Morphic Holding operating profit 2019-2023
- Caribou Biosciences revenue 2019-2023
- Caribou Biosciences operating profit 2019-2023
- Caribou Biosciences total equity 2019-2023
- Beam Therapeutics operating profit 2019-2023
- Monte Rosa Therapeutics total equity 2019-2023
- Myriad Genetics total equity 2019-2023